by Ket Patel | Nov 14, 2011 | All Articles For Neurology, Alzheimer's Disease
Major Finding: Monthly infusion with 200 mg gantenerumab, a monoclonal antibody to amyloid-beta, resulted in an average 15% decline in the amount of brain amyloid-beta in patients with mild to moderate Alzheimer’s disease. Data Source: Randomized trial of 16...
by Ket Patel | Nov 14, 2011 | All Articles For Psychiatry, Sleep Disorders
A series of “on-off” switches regulates sleep, clarifying many of the mechanisms underlying narcolepsy, cataplexy, and REM sleep behavior disorder, according to Dr. Clifford B. Saper. The states of sleep and wakefulness and rapid eye movement and non-REM sleep can...
by Ket Patel | Nov 14, 2011 | All Articles For Neurology, Multiple Sclerosis
Serum levels of interleukin-7 helped determine which patients with relapsing-remitting multiple sclerosis would benefit from treatment with interferon-beta in a series of experiments involving human sera and mice with experimental autoimmune encephalo-myelitis....
by Ket Patel | Nov 12, 2011 | All Articles For Neurology, Epilepsy
Several new antiepileptic drugs and devices aimed at preventing or suppressing seizure have achieved results with better management of side effects than is seen with existing therapeutic agents, according to Dr. Jacqueline A. French. “You may hear many people saying...
by Ket Patel | Nov 4, 2011 | All Articles For Neurology, Movement Disorders
Major Finding: Exercise and medication use significantly improved cognitive function in patients with Parkinson’s disease based on results of the Stroop Color and Word Test. Exercise improved performance on the Brief Test of Attention and the Digit Span Forward...
